Becton, Dickinson and Co. (BDX)
NYSE · Manufacturing · Surgical & medical instruments & apparatus
$183.82+$4.59 (+2.56%) on the dayAs of the close; data may be delayed.
BDX price, last 12 months
Key stats
- Previous close
- $179.23
- Open
- $179.22
- Day range
- $177.87 – $183.92
- 52-week range
- $140.11 – $213.08
- Volume
- 1.5M
- Avg volume (20 days)
- 1.8M
- Market cap
- $50.1B
Performance
1W+1.6%
1M−3.4%
3M+17.9%
6M+16.8%
YTD−5.3%
1Y−1.2%
vs S&P 500, 1Y−18.0 pts
Technicals and fundamentals
About Becton, Dickinson and Co.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NYSE
- Market cap
- $50.1B